|
EUROPEAN COMMISSION
Collection/compilation agency: European Commission
Collection/compilation type: Interviews or postal inquiries.
Variables:
- Public R&D spending
- Biotech-related programmes and sub-programmes
- Research infrastructure
- Participation in EU programmes
- Promotion of industry links
- Number of researchers
- Policy targets in relation to biotechnology
- Non-profit organisations involved in R&D etc.
Scope: Publicly funded biotechnology R&D stimulation programmes in 17 European countries.
Excluding research carried out at universities and private laboratories.
Frequency: Onetime study terminated in 1999.
Periodicity: Study covered the 1994 98 period.
Classification used: “The widely recognised OECD definition of biotechnology (The application of scientific and engineering principles to the processing of materials by biological agents to provide goods and services) together with the European Federation of Biotechnology one (“The integrated use of natural sciences and engineering sciences by the application of biosystems – cells of microbial, plant and animal origin, parts thereof and molecular analogues – in bioindustries”) have been used. However, some Member States might have applied different concepts, reflecting the various ways biotechnology is used in each country (EC, DGXII, Biotechnology R&D in Europe: National Files, 1996).
Output:
Inventory of Public Biotechnology R&D Programmes in Europe: Volume 1 - 1999: an analytical report.
Inventory of Public Biotechnology R&D Programmes in Europe: National Reports Volume 2. - 1999. Austria-Ireland.
Inventory of Public Biotechnology R&D Programmes in Europe: National Reports Volume 3. - 1999. Italy-United Kingdom + Index.
Contact comments:
Each national file, included in Volumes 2 and 3, is structured as follows:
- Background: setting the national scene
- The national system for biotechnology funding: policy and instruments
- National competencies and priorities
- Public and private biotechnology infrastructure
- References and people interviewed
http://europa.eu.int/comm/dg12/biotech/biot-pg-pdf.html
Future plans (plans for new collections, strategies, experiences etc.): Follow-up study BIOPOLIS to be started in autumn 2004, results expected end of 2005. Coverage: 30 European countries (14 EU Member States, 10 accession countries, 3 candidate countries, plus Norway, Iceland, and Switzerland). Time-span: 1999-2004. OECD methodology should be used as far as possible, while other kinds of data must be flagged as “not compliant”.
__________
EUROSTAT
Collection/compilation agency: EUROSTAT
Collection/compilation type: Survey on Government Budget Appropriations on R&D – GBAORD.
Variables: Research and Development: Government R&D Appropriations.
Scope: Government sector (appropriations).
Frequency: Annual.
Periodicity: Annual.
Classification used: NABS (Nomenclature for the Analysis and Comparison of Scientific Programmes and Budgets).
Output: NEWCRONOS database.
Contact comments: The following Member States report data on biotechnology: Denmark, Germany, Greece, Spain, Ireland, Italy, and the United Kingdom.
Contact details: http://europa.eu.int/comm/eurostat/
|
